October 24, 2020

The Niche

Knoepfler lab stem cell blog

3-parent technology

4 min read

An FDA committee began a meeting yesterday that continues today to consider permitting new assisted reproduction-based “3-parent” technology that could address mitochondrial disorders, a serious human health problem. The technology also raises complex health issues of its own and invokes ethical questions. The goal of the FDA meeting is articulated this way: “the committee will discuss oocyte modification in assisted reproduction for the prevention of transmission of mitochondrial disease or treatment of infertility.” The technology, given the informal moniker of “3-parent” reproduction by some, …Read More